Aveanna Healthcare (AVAH)
(Delayed Data from NSDQ)
$8.08 USD
-0.15 (-1.82%)
Updated Sep 17, 2025 03:59 PM ET
After-Market: $8.03 -0.05 (-0.62%) 7:58 PM ET
1-Strong Buy of 5 1
B Value A Growth C Momentum A VGM
Fundamental Charts
About Cash from Investing (Quarterly)
The company's quarterly Cash from Investing value is the sum of the company's current quarter cash position resulting from any gains or losses from investments in the financial markets, operating activities, and changes resulting from amounts spent on investments in capital assets such as plant and equipment. When evaluating the Cash from Investing value, it is important to consider each of the various activities which contribute to the overall change in cash position. A company can have a negative cash flow from investing and have a positive cash from Cash from operations or financing.
AVAH 8.08 -0.15(-1.82%)
Will AVAH be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for AVAH based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for AVAH
Aveanna Healthcare Holdings Inc. (AVAH) Hits Fresh High: Is There Still Room to Run?
Encompass Health Corporation (EHC) Hit a 52 Week High, Can the Run Continue?
AVAH: What are Zacks experts saying now?
Zacks Private Portfolio Services
Buying the Best Top-Ranked Stocks in September
Should You Buy Aveanna Healthcare (AVAH) After Golden Cross?
Aveanna Healthcare Holdings Inc. (AVAH) Hit a 52 Week High, Can the Run Continue?
Other News for AVAH
Bain Capital Investors LLC Reduces Stake in Waystar Holding Corp
The technical outlook for AVAH is unchanged after it falls 1.91% on September 16
Bearish Engulfing appears for AVAH after 0.59% move
Deutsche Bank Keeps Their Buy Rating on Aveanna Healthcare Holdings (AVAH)
New 52 Week Closing High appears for AVAH after 0.24% move